-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Yuanda Pharmaceutical (00512.HK) issued an announcement. Recently, the first patient was enrolled in the Phase III clinical study of GPN01360, the Group's innovative traditional Chinese medicine drug for treating depression in China. This is a major milestone in the Group's proprietary Chinese medicine sector.

Zhitongcaijing·07/23/2026 10:25:09
Listen to the news
Zhitong Finance App News, Yuanda Pharmaceutical (00512.HK) issued an announcement. Recently, the first patient was enrolled in the Phase III clinical study of GPN01360, the Group's innovative traditional Chinese medicine drug for treating depression in China. This is a major milestone in the Group's proprietary Chinese medicine sector.